Delivery Order SPE2DB24D2100-SPE2DB25FBEBY
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$54K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA). The $9,738.66 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp on December 19, 2024, with a completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. This is a firm fixed price delivery order contract with a ceiling value of $15,781.48 and a period of performance through March 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp...
The federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication to the Defense Logistics Agency (DLA). The $3,002.96 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 20, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price of $11,362.20 and a completion date of December 5, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a significant Indefinite...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $64,666.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a performance period ending on March 28, 2025. It is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,759.96 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024 with a completion date of December 17, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract, valued at $4,150.96, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on April 19, 2024. This is a delivery order contract, with a firm fixed price pricing type and an ultimate completion date of April 22, 2024. The contract is not designated as a set-aside....
This federal contract award is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $18,473.26 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of December 18, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $18,940.83, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 7, 2024, with an ultimate completion date of October 8, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $7,766.37 and is a firm fixed-price delivery order with a completion date of May 13, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was awarded on May 12, 2025. Amerisourcebergen Drug Corp holds a...